Abstract
We surveyed infection prevention programs in 16 hospitals for hospital-associated methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci, extended-spectrum β-lactamase, and multidrug-resistant Acinetobacter acquisition, as well as hospital-associated MRSA bacteremia and Clostridium difficile infection based on defining events as occurring >2 days versus >3 days after admission. The former resulted in significantly higher median rates, ranging from 6.76% to 45.07% higher.
Publication types
-
Comparative Study
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acinetobacter
-
Acinetobacter Infections / diagnosis*
-
Acinetobacter Infections / epidemiology
-
Bacteremia / diagnosis*
-
Bacteremia / epidemiology
-
Bacteremia / microbiology
-
California
-
Carrier State / diagnosis*
-
Carrier State / epidemiology
-
Carrier State / microbiology
-
Clostridioides difficile*
-
Cross Infection / diagnosis*
-
Cross Infection / epidemiology
-
Cross Infection / microbiology
-
Drug Resistance, Multiple, Bacterial
-
Enterocolitis, Pseudomembranous / diagnosis*
-
Enterocolitis, Pseudomembranous / epidemiology
-
Enterocolitis, Pseudomembranous / microbiology
-
Humans
-
Methicillin-Resistant Staphylococcus aureus
-
Practice Guidelines as Topic*
-
Prospective Studies
-
Staphylococcal Infections / diagnosis*
-
Staphylococcal Infections / epidemiology
-
Staphylococcal Infections / microbiology
-
Time Factors
-
Vancomycin-Resistant Enterococci
-
beta-Lactam Resistance